SEI INVESTMENTS CO - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,411,181
+20.1%
28,100
+51.1%
0.00%
+50.0%
Q2 2023$1,175,398
+84.2%
18,598
+31.1%
0.00%
+100.0%
Q1 2023$638,178
+27.1%
14,185
+23.7%
0.00%0.0%
Q4 2022$502,195
-15.7%
11,463
+26.6%
0.00%0.0%
Q3 2022$596,000
+17.3%
9,051
-10.0%
0.00%0.0%
Q2 2022$508,000
-65.6%
10,062
-56.5%
0.00%
-66.7%
Q1 2022$1,477,000
-60.7%
23,110
-34.0%
0.00%
-57.1%
Q4 2021$3,755,000
+3.1%
35,006
-1.1%
0.01%
-12.5%
Q3 2021$3,641,000
+11.2%
35,383
-4.8%
0.01%
+14.3%
Q2 2021$3,273,000
-55.4%
37,186
-49.6%
0.01%
-61.1%
Q1 2021$7,331,000
+11.3%
73,773
+25.7%
0.02%
+5.9%
Q4 2020$6,584,000
-42.7%
58,700
-52.7%
0.02%
-48.5%
Q3 2020$11,500,000
+27.4%
124,066
+7.2%
0.03%
+17.9%
Q2 2020$9,027,000
+170.0%
115,692
+102.4%
0.03%
+133.3%
Q1 2020$3,343,000
-16.5%
57,164
+14.4%
0.01%0.0%
Q4 2019$4,004,000
+15.2%
49,976
+5.4%
0.01%
+33.3%
Q3 2019$3,477,000
+49.8%
47,408
+92.8%
0.01%
+12.5%
Q2 2019$2,321,000
-3.3%
24,587
-18.1%
0.01%0.0%
Q1 2019$2,401,000
-28.8%
30,038
-30.7%
0.01%
-33.3%
Q4 2018$3,371,000
-0.3%
43,331
-0.0%
0.01%0.0%
Q3 2018$3,381,000
+28.3%
43,340
+4.4%
0.01%
+33.3%
Q2 2018$2,635,000
-7.5%
41,507
+33.6%
0.01%
-18.2%
Q1 2018$2,849,000
-49.3%
31,070
-58.3%
0.01%
-45.0%
Q4 2017$5,619,000
+36.1%
74,508
+25.7%
0.02%
+33.3%
Q3 2017$4,128,000
+125.7%
59,251
+64.1%
0.02%
+114.3%
Q2 2017$1,829,00036,1000.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders